Private Trust Company’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2K Buy
1,472
+550
+60% +$12.6K ﹤0.01% 1597
2026
Q1
$20.3K Hold
922
﹤0.01% 1691
2025
Q4
$10.9K Hold
922
﹤0.01% 1903
2025
Q3
$14.6K Hold
922
﹤0.01% 1763
2025
Q2
$10.6K Sell
922
-20
-2% -$225 ﹤0.01% 1799
2025
Q1
$12.7K Buy
942
+20
+2% +$332 ﹤0.01% 1721
2024
Q4
$15.6K Hold
922
﹤0.01% 1574
2024
Q3
$18.7K Hold
922
﹤0.01% 1497
2024
Q2
$20.8K Hold
922
﹤0.01% 1441
2024
Q1
$24.2K Hold
922
﹤0.01% 1372
2023
Q4
$29.1K Hold
922
﹤0.01% 1265
2023
Q3
$25.9K Hold
922
﹤0.01% 1265
2023
Q2
$34K Hold
922
﹤0.01% 1164
2023
Q1
$27.6K Sell
922
-100
-10% -$3.29K ﹤0.01% 1210
2022
Q4
$31K Hold
1,022
﹤0.01% 1125
2022
Q3
$25K Sell
1,022
-1,499
-59% -$49.4K ﹤0.01% 1119
2022
Q2
$81K Buy
+2,521
New +$92.7K 0.01% 758

Other funds holding CC

Private Trust Company's CC Position: Q2 2026 in Review

Private Trust Company increased its Chemours (CC) stake by 60% in Q2 2026, buying an estimated $12.6K and bringing the position to 1,472 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Private Trust Company first reported a position in CC in Q2 2022 and has held it in 17 quarters since. The position peaked at $81K in Q2 2022. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Private Trust Company held 1,472 shares of Chemours worth $30.2K as of Q2 2026.
  • Private Trust Company bought 550 Chemours shares in Q2 2026, an estimated $12.6K.
  • Chemours made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1597 holding.
  • Private Trust Company first reported a position in Chemours in Q2 2022 and has held it in 17 quarters since.
  • Private Trust Company's Chemours position peaked at $81K in Q2 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.